Dr Reddys submits revised protocol to DCGI for Sputnik V phase 2,3 trials Ruchika Sharma15 Oct 2020 12:45 PM ISTRecently, the expert panel of DCGI had recommended that Dr Reddy's Lab submit a fresh application to the top drug regulator seeking its consideration.
Setback to Dr Reddys: CDSCO panel rejects proposal to test Covid vaccine Sputnik-V due to inadequate data Ruchika Sharma8 Oct 2020 4:06 PM ISTThe recommendations by an expert panel of the Central Drugs Standard Control Organisation (CDSCO) noted that safety and immunogenicity data from...
Dr Reddys unveils generic version of Sapropterin Dihydrochloride Tablets in US Ruchika Sharma5 Oct 2020 12:30 PM ISTHyderabad and Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of a generic version of Sapropterin Dihydrochloride Tablets,...
Dr Reddys seeks DCGI approval to conduct Sputnik V Phase-3 clinical trial Ruchika Sharma4 Oct 2020 11:00 AM ISTUpon regulatory approval in India, RDIF will supply to drugmaker Dr Reddy's 100 million doses of the vaccine, the firm said last month.
Dr Reddys launches generic version of Sensipar tablets in US Ruchika Sharma3 Oct 2020 1:30 PM ISTDr. Reddy's Cinacalcet Tablets are available in 30 mg, 60 mg, and 90 mg tablets in a bottle count size of 30.
Dr Reddys launches OTC eye allergy drop Olopatadine Hydrochloride Ophthalmic Solution in US Ruchika Sharma18 Sept 2020 11:37 AM ISTThe Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% is also indicated for the temporary relief of red eyes.
RDIF collaborates with Dr Reddys for supply of 100 million doses of Sputnik V in India Ruchika Sharma17 Sept 2020 12:34 PM ISTDeliveries could potentially begin in late 2020, subject to completion of successful trials and registration of the vaccine by regulatory authorities...
Dr Reddys unveils generic Fulvestrant injection for breast cancer in US Ruchika Sharma8 Sept 2020 11:40 AM ISTFaslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.
Dr Reddys enters hospital nutrition segment with launch of Celevida Maxx in India Ruchika Sharma26 Aug 2020 1:26 PM ISTDr Reddy's Celevida Maxx contains a unique triple action formula of high protien, high omega 3 fatty acids to help tackle the problem of inflammation...
Dr Reddys unveils generic Ciprodex in US to treat bacterial infection Farhat Nasim11 Aug 2020 3:31 PM ISTNew Delhi: Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%)...
FY21: Dr Reddy's Q1 results to be released on July 29th Ruchika Sharma22 July 2020 9:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd. has recently said that the company will announce results for the first quarter ended June 30, 2020, on...
Covid-19 impact: Sale of cardiac, anti-diabetic drugs surge Ruchika Sharma18 July 2020 3:21 PM ISTThe sudden change in preferred therapies by masses has just taken a sharp turn from pre-Covid period when gastric, vitamin therapies were most widely...
